Informing on health and wellness news in Djibouti

Provided by AGP

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on April 22, 2026

Stereotaxis Announces First MAGiC Procedures in the United States
Glyco Harmony Drops Examined - 2026 Consumer-Focused Report on Ingredients, Claims & Label Insights
Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call
Repligen to Report First Quarter 2026 Financial Results
CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology
Luminoah Announces FDA Clearance of the Luminoah Flow Enteral Nutrition System, A Brighter Future for Tube Feeding
Coave Therapeutics to present two posters at ARVO 2026, on first-in-class ligand-conjugated suprachoroidal vector and lead gene therapy program
Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026
Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer
Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting
维泰瑞隆宣布其SARM1抑制剂SIR2501相关摘要获选2026年美国临床肿瘤学会(ASCO)年会海报展示
維泰瑞隆宣佈其SARM1抑制劑SIR2501相關摘要獲選2026年美國臨床腫瘤學會(ASCO)年會海報展示
Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting
Ocular Therapeutix™ to Host Investor Day on June 17, 2026
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer
NeurAxis Expands Payer Coverage with Four New Medical Policies
BlossomHill Therapeutics Presents First Preclinical Data from New Pan-KRAS Inhibitor Program Built on a Novel Chemical Scaffold During Mini Symposium at AACR 2026

Share us

on your social networks:

Sign up for:

Djibouti Health Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.